The measurement of dexmedetomidine for sedation in intensive care patients

The measurement of dexmedetomidine for sedation in intensive care patients - The measurement of dexmedetomidine in intensive care patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009115

Enrollment

Registered

2012-10-15

Start date

2012-10-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intensive care patients

Interventions

Dexmedetomidine is administered for sedation in intensive care patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Intensive care patients

Exclusion criteria

Exclusion criteria: BMI>35 or BMI <17

Design outcomes

Primary

Measure	Time frame
To investigate the relation between the plasma level of dexmedetomidine and the method of administering dexmedetomidine	—

Secondary

Measure	Time frame
To assess the sedative effect with the plasma level of dexmedetomidine	—

Countries

Japan

Contacts

Public ContactYoshihito Fujita

Nagoya City University Graduate School of Medical Sciences Department of Anesthesiology and Medical Crisis Management

masui@med.nagoya-cu.ac.jp052-851-5511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026